Robaxin vs. Baclofen
See how Robaxin and Baclofen compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Robaxin and Baclofen are both muscle relaxants, but Robaxin is approved for short-term acute muscle spasm while Baclofen is approved for spasticity from MS or spinal cord injury.
Baclofen requires a gradual taper because stopping it abruptly can cause seizures or rebound spasticity, while Robaxin carries no such withdrawal risk.
Robaxin is not a controlled substance and comes in oral and injectable forms, while Baclofen offers more formulations plus an intrathecal pump for severe spasticity.
Robaxin vs. Baclofen Drug Summary
Robaxin
Robaxin (methocarbamol) is a centrally-acting skeletal muscle relaxant used short-term for acute, painful musculoskeletal conditions, usually alongside rest and physical therapy. It comes as an oral tablet and also as an IV/IM injection used as adjunct therapy in tetanus. Robaxin is not a controlled substance and has been used since 1957.
Baclofen
Baclofen is a GABA-B receptor agonist used to control spasticity from multiple sclerosis, spinal cord injury, or other spinal cord disease. It is taken orally several times a day, with a severe-spasticity intrathecal pump version available for cases that do not respond to oral therapy. Baclofen has been used since 1977 and comes in tablet, solution, suspension, and granule forms.
Robaxin vs. Baclofen Side Effects
Robaxin
Baclofen
Robaxin vs. Baclofen Dosage
Robaxin
Baclofen
| STAGE | DOSE | WHEN |
| Starting dose | 1500 mg four times daily | Days 1-3 |
| Maximum dose | 1000 mg IM/IV per dose | If needed |
| Dose changes | 2 increases | Every 3 days |
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg three times daily | Days 1-3 |
| Maximum dose | 20 mg four times daily | If needed |
| Dose changes | 4 increases | Every 3 days |
Robaxin
| STAGE | DOSE | WHEN |
| Starting dose | 1500 mg four times daily | Days 1-3 |
| Maximum dose | 1000 mg IM/IV per dose | If needed |
| Dose changes | 2 increases | Every 3 days |
Baclofen
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg three times daily | Days 1-3 |
| Maximum dose | 20 mg four times daily | If needed |
| Dose changes | 4 increases | Every 3 days |
Robaxin vs. Baclofen Indications
Robaxin
Robaxin is FDA-approved as an adjunct to rest and physical therapy for the discomfort of acute, painful musculoskeletal conditions. The injectable form is also used as adjunctive therapy in tetanus. It is intended for short-term use, not long-term pain management.
Short-term relief of acute muscle spasm and pain
Used alongside rest and physical therapy
Injectable form used as adjunct in tetanus treatment
Not approved for chronic pain or long-term use
Not approved for children under 16
Baclofen
Baclofen is FDA-approved to treat spasticity caused by multiple sclerosis or by spinal cord injury and disease. Severe, treatment-resistant spasticity can be managed with an intrathecal pump that delivers baclofen directly to the spinal fluid. It is also used off-label for alcohol cravings, hiccups, and reflux.
Treats spasticity from multiple sclerosis
Treats spasticity from spinal cord injury or disease
Severe spasticity treated via intrathecal pump
Off-label use for alcohol cravings, hiccups, or GERD
Not approved for stroke, cerebral palsy, or Parkinson's spasticity
Robaxin vs. Baclofen Pros and Cons
Robaxin
Robaxin offers a straightforward option for short-term muscle spasm relief without the controlled-substance status carried by some other muscle relaxants. It is available in both oral and injectable forms, giving flexibility for acute care settings. Its label describes side effects qualitatively rather than with specific percentages.
Pros
Not a federally controlled substance
Available in oral and IV/IM injectable forms
No dangerous withdrawal syndrome if stopped abruptly
Long history of use since 1957
Cons
Not approved for spasticity from MS or spinal cord injury
Not approved for chronic or long-term pain
Side effect rates not quantified in labeling
Not approved for children under 16
Baclofen
Baclofen is the more targeted option for spasticity tied to neurological conditions like MS or spinal cord injury, with strong evidence in that population. It requires a careful taper, since stopping it abruptly can trigger serious withdrawal symptoms including seizures. Its dosing schedule is more gradual and multi-step compared to Robaxin's.
Pros
FDA-approved specifically for MS and spinal cord spasticity
Intrathecal pump option for severe, treatment-resistant cases
Multiple formulations (tablet, solution, granules) for flexible dosing
Off-label options for alcohol cravings, hiccups, and GERD
Cons
Requires gradual taper to avoid seizures or rebound spasticity
Needs dose adjustment in kidney impairment
Drowsiness reported in up to 63% of patients
Not approved for spasticity from stroke or cerebral palsy
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.